The FDA announced today that it authorized the Neurolutions IpsiHand upper extremity rehabilitation system for stroke rehab.
De novo authorization encompasses patients 18 years of age and older who are undergoing stroke rehabilitation to facilitate muscle re-education and need to maintain or increase their range of motion, according to a news release. It is a brain-computer-interface (BCI) device that assists in rehabilitation for stroke patients with upper extremity or hand, wrist and arm disability.
Get the full story at our sister site, Medical Design & Outsourcing.
